Your voice can’t be heard… UNLESS YOU SPEAK UP !

Chronic Pain Patient To Be Heard? Take the Survey!

http://www.nationalpainreport.com/chronic-pain-patient-to-be-heard-take-the-survey-8830008.html

By Ed Coghlan

The U.S. Pain Foundation is the largest pain advocacy group in the United States. It has been sharpening its message in recent weeks on the importance of the U.S. pain community coming together in a common voice, as evidenced by this op-ed by their President that the National Pain Report published last week.

In an email communication to the thousands of members and associates they boast, they have asked the pain community to complete a survey that has the goal of uniting the pain community to advocate for improved access to quality health care.

They asked the National Pain Report if we would promote the survey, which we agreed to do because it is our belief that hearing the voice of the chronic pain patient is critical.

Here’s a link to the survey, which we recommend that you take. If real change is going to occur, it has to start somewhere. The voice of the chronic pain patients and their families/loved ones seems like a good place to start.

As the U.S. Pain Foundation said in the email: “We have been working to unite the pain community to advocate for further pain research, fair access to all forms of care (including integrative and complementary therapies) and legislation that fulfills the needs of people with pain.

While U.S. Pain continues to educate the general public and healthcare professionals to better understand chronic pain as a disease, it is imperative to discover how we, as pain warriors, can mobilize our efforts to make positive change at the federal level.”

The organization addressed the major issue in chronic pain treatment today – the federal agency emphasis on addressing the abuse and misuse of pain medication.

U.S. Pain is collecting data to gain a sense of how much information is known about the CDC Guidelines for Prescribing Opioids for Chronic Pain, FDA Opioids Action Plan and the National Pain Strategy (NPS).

“To move the pain community forward, toward a nation which can support and acknowledge chronic pain as a disease and addiction as a disease, pain patients, caregivers and providers are needed to weigh in on the questions below,” they said.

Substance abuse: compulsive drug use despite negative consequences

PrisonerDrug addiction should be treated like a learning disorder – not a crime

People who misuse drugs are often jailed – the US has 25% of the world’s prisoners. But learning-based treatment would work much better

http://www.theguardian.com/commentisfree/2016/apr/05/drug-addiction-treatment-learning-disorders?utm_source=esp&utm_medium=Email&utm_campaign=GU+Today+USA+-+Version+CB+header&utm_term=165432&subid=13529055&CMP=ema_565

Since entering recovery 28 years ago, I’ve spent a great deal of time thinking about the conundrum of addiction. The most commonly accepted definition – the one used in psychiatry’s Diagnostic and Statistical Manual, the DSM – can be summarized as “compulsive drug use despite negative consequences”. It’s completely odd, then, that we treat punishment, which is just another word for “negative consequences”, as the best way to stop it.

During my addiction to heroin and cocaine in my 20s, I kept using despite getting suspended from Columbia University, which I’d worked most of my conscious life to be able to attend. I kept injecting despite losing friends – though difficulty socializing was one of the main reasons I took drugs in the first place. I kept on despite the risk of overdose death, disease, the disappointment of my family and the stigma.
And yet the US has some of the toughest drug sentences in the world. American drug policymakers expect fears and harsh consequences – like arrest and incarceration – to stop addicts like me from using illegal drugs. Instead, to begin addressing America’s opioid epidemic, we need to recognize addiction as the specific type of brain health issue it really is: a learning disorder – specifically, one characterized by failure to learn well from punishment.

Why is learning so important in addiction? For one, addiction can’t occur without it. If you don’t learn that a drug makes you feel better (at least at first) and then continue to take it to cope even when it does more harm than good, you can’t be addicted. If you don’t learn the connection between the drug and its effects, you basically wouldn’t even know what to crave, so you couldn’t pursue it.

Second, like other developmental disorders – such as ADHD, dyslexia, autism and schizophrenia – addiction unfolds as the brain matures through specific stages and the person responds to formative experiences. ADHD and autism, for instance, tend to start producing symptoms in early childhood, while schizophrenia does not usually appear until adolescence and early adulthood.

Addiction, too, is overwhelmingly a disorder of emerging adulthood. Ninety percent of all addictions begin during the teens and 20s. This isn’t coincidental: during this time, the circuitry of the brain involved in love and parenting begins to come online, and it is this same system that goes wrong in addiction. When vulnerable people – particularly those predisposed to mental illness and those who have experienced childhood trauma – reach their teens, they often learn that drugs ease their way into the social connections that are so important at this age.
If we want to end the opiate epidemic, prisons are a good place to start
Chandra Bozelko
Read more

Essentially, addiction occurs when you fall in love with a drug rather than a person. Love wires memories into the brain very differently than learning abstract subjects like math typically does. And love requires that you persist despite negative experiences – no one could be a good parent or partner without doing so, at least to some extent. But if you bring that persistence and the sense that this relationship is crucial to your survival to your connection with a drug, serious problems can ensue.

The good news about addiction as a learning disorder is that the learning that occurs doesn’t “break” your brain. Instead, what happens is, again, very similar to the changes seen when someone falls in love or becomes a parent. These experiences profoundly shift values and priorities – and they can lead people do things that they otherwise wouldn’t. But they don’t eliminate free will, they simply skew it, which is why the relationship between addiction and choice is so difficult to describe.
Advertisement

Still, just as most people can get over breakups, the same is true for addiction. Research shows that half of all addictions – including those to heroin and opioids – end by age 30, with the exception of tobacco. In my case, I quit at 23, right at the age when research suggests that the parts of the brain that maximize self-control finally become mature. I chose to attend rehab on my own, two years after an arrest for dealing, which had actually worsened my drug use by terrifying me about my future. It wasn’t fear of negative consequences that allowed me to quit.

The US incarcerates more people than anyone else; with 5% of the world’s population, we have 25% of its prisoners. Overdose now kills more people than car accidents. The war on drugs, with its complete misunderstanding of addiction, is a large contributor to the problem.

Understanding addiction as a learning disorder, then, has profound implications for all aspects of drug policy. If we want to do better, we need evidence-based treatments, prevention programs and other policies that recognize the role of learning and development – and we must stop trying to use punishment to fight a condition that is defined by its lack of response to negative experience.

 

Lack of efficacy studies .. means no efficacy of opiates ?

Pharmacotherapy options for noncancer pain: an efficacy review

http://www.clinicaladvisor.com/pain-management-information-center/treating-noncancer-pain-with-acetaminophen-nsaids-instead-of-opioids/article/487282/

Strong opioids are no more effective than acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with musculoskeletal disease and other forms of noncancer pain, according to a review published in Joint Bone Spine.1

Strong opioids, including morphine, fentanyl, and oxycodone, have been on the top step (step III) of the World Health Organization (WHO) analgesic ladder for many years. However, it may be time to rethink this model; when it comes to noncancer pain, strong opioids are neither strong nor effective.

“This is a review, so there is nothing here [that] we don’t already know — in fact, there is not much evidence for use of any opioids for longer than 3 months,” Troy Buck, MD, an assistant professor of anesthesiology and pain management from Loyola University Medical Center in Maywood, Illinois, told Clinical Pain Advisor.

Jahangir Maleki, MD, a pain management specialist at the Cleveland Clinic’s Center for Neuro-Restoration, agrees that opioids may be overestimated for pain. However, they have other important benefits, he notes.

“In terms of other good indications, there are many. I would invite the authors of this review to join an anesthesiologist for a day. They would see what opiates are capable of delivering before, during, and after any surgery. Opiates [achieve] more than just analgesia. Sedation, relaxation, and mood elation are great benefits, if used properly in acute conditions,” Dr Maleki told Clinical Pain Advisor.
What the Research Shows

The review authors note that there is a “stunning” lack of high-quality studies on the efficacy of step III analgesics, especially given their widespread use and abuse. Among their findings:1

Several randomized, double-blind, emergency-room trials found that IV acetaminophen was similarly effective or superior to IV morphine in patients with conditions such as renal colic, low back pain, and acute limb pain.
In a trial of 137 patients with intense and acute limb pain, there was no difference in pain relief between 1 gram of IV acetaminophen and 0.1 mg/kg of IV morphine.
In 31 studies of chronic neuropathic pain, opioids were only slightly more effective than placebo.
A meta-analysis of oxycodone used to treat diabetic neuropathy, postherpetic neuralgia, or fibromyalgia concluded there was no proof of efficacy, but there were more side effects.
A systematic review of opioids for osteoarthritis pain found them no more or less effective than NSAIDs.

All of these studies examined opioid doses below 100 mg/day morphine-equivalents. Although higher opioid doses may achieve greater analgesia, are they worth the cost?

“Getting into higher doses for any condition brings into play issues of tolerance, dependence, respiratory depression, and at very high doses, hyperalgesia,” Dr Buck pointed out.

The authors note that pain specialists in the United States have issued a petition supporting restrictions to strong opioid use in noncancer pain, limiting doses to less than 100 mg/day morphine-equivalents, for a maximum of 100 days. The action reflects the sobering statistic that opioids contribute to more than 10 000 deaths in the United States each year.1

“The fact is that opiates are great drugs if they are used properly for acute pain, but they fail miserably when we use them as a Band-Aid. We need to realize that most of the world’s opiates are sold here in the US. If opiates were truly the painkillers we thought, we would have eliminated pain from every corner. Not only haven’t we eliminated pain, [but] the opiate epidemic has directly resulted in [an] ever-growing number of drug overdoses,” said Dr Maleki.

What About Cancer Pain?

Although the mean dose of morphine for cancer pain ranges from 100 to 250 mg/day, doses exceeding 1000 mg are not unusual and have been studied in a few placebo-controlled trials. Results tend to show a good initial analgesic effect, especially for fentanyl, followed by decreasing efficacy and increasing toxicity over time. A Cochrane review of 62 trials involving more than 4000 patients found that adequate analgesia was only achieved in 29% of studies.1

The “war on pain” that was started 20 years ago has relied heavily on opioids. Is it time to say that opioids have lost the war on pain?

“I would not go that far,” said Dr Buck. “Opioids are still well indicated for acute and severe pain, such as in the post-op setting — but they are rarely indicated for chronic pain.”
Future Prospects and Key Takeaways

The development of new analgesics and new nonpharmacological approaches may be our best hope for future pain management, the authors write.

“There is no game changer on the horizon as far as new analgesics. I think [that] the future of pain management may lie more in nonpharmacological treatments, like spinal cord stimulation, peripheral nerve stimulation for neuropathic pain, and cognitive behavioral therapy interventions,” Dr Buck said.

“Primary care providers should be aware that the bulk of opioid prescriptions are distributed by general practitioners,” Dr Maleki said, noting that these clinicians are the first to field the acute onset of chronic pain.

“Primary care providers play a crucial role in preventing transition of acute pain into chronic pain. Patient education, lifestyle changes, proper diet, stress reduction, and adequate exercise, along with use of non-opioid medications are the primary management tools,” Dr Maleki concluded.
Reference

Berthelot JM, Darrieutort-Lafitte C, Le Goff B, Maugars Y. Strong opioids for noncancer pain due to musculoskeletal diseases: Not more effective than acetaminophen or NSAIDs. Joint Bone Spine. 2015 Dec;82(6):397-401. doi: 10.1016/j.jbspin.2015.08.003. Epub 2015 Oct 6.

This article originally appeared on Clinical Pain Advisor.

Obama: more save the addicts… CPP… let them take a NASID ?

Obama Sets Task Force to Ensure Access to Addiction Tx

President warns about possible mandatory provider training

http://www.medpagetoday.com/Psychiatry/Addictions/57016
ATLANTA — Noting that the opioid abuse and heroin epidemic “is affecting everybody — young, old, men, women, [and] children,” President Obama launched a federal task force Tuesday to address the issue.

The Mental Health and Substance Use Disorder Parity Task Force will work to ensure access to coverage for behavioral health issues, Obama said here at the National Rx Drug Abuse and Heroin Summit.

The task force builds on the approach of the Mental Health Parity and Addiction Equity Act of 2008 in requiring that health insurance policies cover mental health and substance abuse treatment on par with treatment for physical illness; the group also will help enforce parity provisions included in the Affordable Care Act. The task force will identify best practices for compliance with parity laws and problem areas, in particular challenges accessing substance use disorder treatment.

“When it comes to how we oversee the parity provision in the [Affordable Care Act] we’ve got to let the insurance carriers know that we’re serious,” he said.

The group comprises directors from seven government agencies, including the departments of Treasury, Defense, Justice, Labor, Health and Human Services (HHS), and Veterans Affairs, as well as the Office of Personnel Management and the Office of National Drug Control Policy, according to a press release issued by the White House.

The director of the Domestic Policy Council will chair the group, and HHS will be responsible for funding and administrative support. The task force will release a report of its findings to the President on or before Oct. 31, 2016.

At the summit, the President also pressured Congress to approve his $1.1 billion funding request to address the crisis.

“For all the good work that Congress is doing, it’s not enough just to provide the architecture and the structure for more treatment; there has to be actual funding for the treatment,” he said.

The President also applauded the 60 medical schools who have pledged to require their students to receive training in prescriber education in order to graduate. He warned about possibly making some provider training mandatory.

“I think the medical community worries about their independence and over-regulation,” Obama said. “We have been getting some good volunteer efforts going … If in fact the training is not sufficient we may have to take a look at the possibility of mandatory training.”

Also on Tuesday, the Centers for Medicare and Medicaid Services (CMS) issued a final rule to bolster access to mental health and substance abuse disorders for low-income Americans enrolled in Medicaid and CHIP, to reflect the offerings of private insurance plans.

“Today’s rule eliminates a barrier to coverage for the millions of Americans who for too long faced a system that treated behavioral health as an unequal priority,” said HHS Secretary Sylvia Burwell in a press release. She stressed that the new rule would increase access to evidence-based treatments for substance use disorders specifically, and allow states the option of offering services through managed care models outside of Medicaid.

The new rule also requires states to explain any denial of reimbursement or payment for services associated with mental health and substance use disorder benefits.

A White House press release also highlighted additional efforts from HHS, the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Office of National Drug Control Policy (ONDCP), which include:

An HHS proposal to increase the cap on the number of patients to whom qualified clinicians can prescribe buprenorphrine from 100 to 200
$94 million in new funding from HHS to allow 271 community health centers in high-need areas to expand their substance use disorder services
New guidance from HHS for programs focused on using federal funds to grow syringe service programs
$11 million in grants from SAMHSA to help 11 states increase access to medication assisted treatment and training in high-need areas to qualify more physicians to prescribe buprenorprine

Expansion of the ONDCP’s High Intensity Drug Trafficking Area program to two additional states — Ohio and Michigan

Patrice Harris, MD, a psychiatrist, chair-elect of the American Medical Association (AMA), and chair of the AMA Task Force to Reduce Opioid Abuse, also spoke at the summit, noting that physicians must take responsibility for ending the epidemic.

She spoke of the recent drop in opioid prescriptions, 2.9% nationally from 2013 to 2014 and 6.8% from 2014 to 2015, according to a press release. However, she stressed the need to focus not on shrinking these numbers but on providing appropriate care.

“Patients with pain deserve our care and compassion – not our judgment. The key is to ensure that we are providing the most effective treatment possible, which may or may not include opioids,” Harris said.

Chuckle of the day ! Think next time a WAGS’ RPH tells you “I’m not comfortable”

lmaoWalgreens Pharmacist Intervention Proven to Improve Adherence to New Therapy

http://www.pharmacytimes.com/news/walgreens-pharmacist-intervention-proven-to-improve-adherence-to-new-therapy

Walgreens’ community pharmacist intervention program boosts medication adherence rates and lowers related costs for patients with a wide range of chronic diseases, a recent study demonstrated.
 
This intervention program includes in-pharmacy patient counseling, medication therapy management (MTM), and online and digital refill reminders. For new-to-therapy patients, the program includes pharmacist calls and consultations, and for those continuing therapy, the program includes MTM consultations, automated reminders, pickup reminders, late-to-fill reminders, and face-to-face consultations.
 
Researchers analyzed data from 72,410 patients, including those who started a new therapy from among 16 drug classes for chronic conditions, over a 6-month period in 2013. The Walgreens patient data were then directly compared with patient data from other pharmacies and controlled for a range of factors, including drug class, demographics, clinical factors, prior health care utilization, and costs.
 
The study, which was published in the peer-reviewed journal Population Health Management, found that Walgreens’ multifaceted program resulted in 3% higher medication adherence rates and about 2% lower hospital admissions. Broken down further at the patient level, the data revealed that the Walgreens intervention group incurred lower total health costs (-$226) over a 6-month period.
 
“This data quantifies the role our community pharmacy platform plays in achieving better population health outcomes,” stated study author Michael Taitel, PhD, Walgreens senior director of health analytics, research and reporting, in a press release. “These findings clearly illustrate that the combination of pharmacist counseling, medication therapy management, refill reminders, and telephonic and digital pharmacy interventions tailored to patients’ needs drive better adherence.”
 
While greater pharmacist involvement in patient care isn’t a novel concept in the health care arena, Walgreens Chief Medical Officer Harry Leider, MD, said this study provides strong evidence that patients who are new to therapy can benefit greatly from some combination of pharmacy and digital interventions.
 
The prospect of higher medication adherence rates and lower hospital admissions holds significant value for the entire US health care spectrum. Studies have shown that medication adherence rates are as low as 50% among patients with chronic diseases, which costs the US health care system $289 billion annually. 

Come join us

!cid_logo

www.livesupportgroup.com

Fibromyalgia and Chronic Fatigue affects some 6 million people in the USA with the vast majority being women.

I have been participating in some of the Live Support Groups (LGS)  chronic pain weekly meetings for the last few months.  On April 14th at 8:00 PM (EDT) LSG will inaugurate  a new weekly group for Fibromyaliga and Chronic Fatigue and I will be the facilitator for the weekly meeting.

These meetings are anonymous (first name only) but you must “join” the group by going to www.livesupportgroup.com and click on the JOIN icon and you will be sent a link every week to join the group discussion over the web.  You can use your computer, smart phone or computer tablet to join the conversation.  There is no cost to join in… there is no selling of products… there are no dues… The discussion is scheduled for ONE HOUR but feel free to come in late and/or leave early. You are also welcome if you just want to listen in on the conversation.

bethere

Dear Healthy People: Opiate Withdrawal

400,000 die each year from medical errors

stevemailbox

The procedure was successful.. the pt died of complications ?

I logged on thinking I’d delete some of my “rants” and posts about people being denied pain medicine. Instead I read that a 70 year old man, on blood thinners for a heart condition, was told to take ibuprofen for post-surgical hip pain; told those “heroin pills” are bad, He is now in ICU bleeding out :'(  Another man’s neurologist abruptly stopped his pain medicine; he had a massive stroke due to blood pressure spikes from severe pain. He is now on life support. WHEN will #PatientsNotAddicts lives matter?!  #prop and #andrewkolodny must be so proud of themselves. #opiates alleviate pain, just as they were designed to do. GOD HELP US! #SaveUsACLU #chronicpain #PainIsReal #GivePainAVoice #painedlivesmatter #dontpunishpain #PainWarriors

 

Medical Licensing Board primary charge… protect the public’s health and safety

RxtotheheadGolden Rule: In memory of Robert ‘Bob’ Mason

http://helenair.com/news/opinion/golden-rule/article_b5ad0c5d-ef3e-59d4-9921-9b8eb3bd31e5.html

Last week, like many other recently, saw a couple of twists and turns in the “ongoing saga” of “embattled” Helena physician Mark Ibsen.

On Tuesday, the state board of medical examiners indefinitely suspended his medical license on the grounds of failure to meet standards of care in his record-keeping.

Two days later, District Judge James Reynolds suspended the board’s suspension by issuing a temporary restraining order and injunction against it, thereby granting Ibsen at least 30 more days to practice the healing art.

Ibsen’s “ongoing saga” with BOME began in July 2013, when an investigation into allegations of over-prescription of painkillers began. Despite the fact that a hearing officer for the Montana Department of Labor and Industry later deemed Ibsen’s pain-pill prescriptions were for legitimate medical reasons and said that he employed and encouraged alternatives to medication for chronic pain, the case wears on.

But today is not the time further focus on Ibsen’s dedication to pain patients or BOME’s dedication to keeping him from the Hippocratic oath. Today is dedicated to Robert “Bob” Mason, a chronic pain patient caught in the crossfire. No ink has yet to be spilled over him.

About 20 members of the public showed up at or phoned into Tuesday’s hearing — many of them (former) patients and colleagues. Several of them said they were participating not only in support of Ibsen, but also in memory of Mason.

Here’s what I’ve been able to find out about him, mostly from Ibsen anecdotally but not from Ibsen’s records, to which the doctor no longer has access.

Robert “Bob” Mason was born 65-some years ago, maybe in New York state. He died in Helena on Jan. 16, 2016, of a self-inflicted gunshot wound to the chest. 

 
 

Bob went to college, had at least two sons and a daughter and worked with children, possibly at Head Start. He could have been any of us.

Then, something happened to his back somewhere along the line, requiring surgery. The procedure was botched, leaving Bob in abject pain and misery with something common enough to have a name, “failed back surgery syndrome.” Failed back surgery syndrome hijacked Bob’s life and left him on the margins of society.

Pain medication afforded him some relief, but the current political climate and fear often denied him access to it. Doctors dropped him or were not allowed to prescribe what he needed at the level he needed it.

He had suicidal thoughts, but only when he was in withdrawal, which is where he found himself this winter a couple weeks after losing access to a prescribing doctor on Dec. 31.

When he showed up to support Ibsen at his seven-hour hearing on Jan. 14, “he was completely out of medication and it showed.”

Two days later, he was gone, until now without a trace.

Peace, Bob Mason, peace.

Leah Gilman plans to honor Bob Mason’s memory at the voting booth this fall.

Is documenting care becoming more important than providing care ?

A physician’s open letter to Medicare patients

http://www.kevinmd.com/blog/2015/11/a-physicians-open-letter-to-medicare-patients.html#comments

Dear patients,

This is a hard letter to write, but it is important that you know about a major change that is coming for both of us in 2017, just a short year away.

As you recall, last year I left a large hospital group practice and opened my own office, and I want to thank you for your faithfulness in following me to my new location. With the newfound freedom of running my own practice, I love being your doctor more than ever.

As a family physician in Southwest Florida, the majority of my patients are insured by Medicare, and you, my Medicare patients, are very important to me. Not just for my financial livelihood, but because of the relationships that we have formed together over the last 15 years in this community.

I have welcomed you to Medicare with screening tests, explaining the risks and benefits, and keeping you up to date with the constant changes in guidelines. I cared for you through various medical crises, and helped you to control your chronic diseases. I was there to treat your acute illnesses, and coordinate your care with your various medical specialists. I requested prior authorizations when your preferred drugs weren’t covered, and helped you get free medicines when you were in the donut hole. I did your preoperative clearances, your disabled parking forms, and the pages of paperwork you needed when we decided it was time to consider transitioning into an assisted living facility. We’ve talked about end-of-life issues, and I’ve helped you understand advance directives and DNR forms. I’ve visited you in hospice, and even held your hand as you died.

This is the side that you know about, and the part that is most important to both of us. But unfortunately, what I have described is only half of my reality. The other half is the regulatory burden that I have to bear in order to provide your medical care.

For every office visit that we spend together, I spend at least as much time on what Medicare deems as necessary documentation, especially a new program called meaningful use. While the goals of meaningful use in improving quality of health care are admirable, the regulatory burden is intense. To comply with Medicare requirements, I’ve had to spend thousands of dollars and massive amounts of time instituting electronic health records, adapting my practice to conform to the computer technology that wasn’t created to help me, your physician.

During and after every visit, I type away at my keyboard, clicking boxes to demonstrate to Medicare that I did my job. My notes, which used to be informative and succinct, now include pages of irrelevant information, disclaimers and computer-generated statements to “document” that I am playing by the rules.

But even though I detest some of these new processes, I know that if I want to care for you, my Medicare patients, I must do everything that I can to follow the rules, no matter how burdensome. You see, the problem isn’t just that the doctor doesn’t get paid if she fails to follow the letter of the law. If Medicare detects any questionable billing processes or inadequate documentation, honest or not, the physician faces heavy fines and even jail time.

And I get it. Costs have to be contained, and true Medicare fraud, unfortunately, does exist. There is no doubt that medical costs have been spiraling upwards for years, and as our Baby Boomer generation reaches Medicare age, naturally our health care spending will have to increase in turn.

Although physician payments only make up about 10 percent of the cost of health care in the United States, the government has looked to increasing regulation on physicians as a way of reining in cost. And next year the whole ballgame changes for physicians as the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) goes into full effect, with a complete paradigm shift in Medicare payment from “fee-for-service” (I send a bill for your medical care, Medicare pays me), to “value-based payment” (I submit a bill, and I get paid if Medicare thinks that I’ve done a good enough job).

Basically, in 2017, all doctors that care for Medicare patients will have to make a choice. The first option is to join an accountable care organization (ACO), which is a large group that acts kind of like an HMO to control costs and accept financial risk. Having just left a large hospital system with daily productivity reports and a glut of middle managers, this option does not appeal to me.

The second option, for those who choose to stay in solo or small practices, is for the physician to enter into a Merit-Based Incentive Payment System (MIPS), in which payment will be determined by where the doctor ranks on a physician scorecard. The kicker is that the pot of money remains constant – so even if every doctor makes an ‘A’ grade, half of them will be paid less money, just by nature of this “budget-neutral” payment system.

And of course, this system begs the question: what happens to the doctors who care for sicker or less compliant patients? Will doctors have to cherry-pick, dismissing patients simply because they choose not to take a statin drug for cholesterol? What doctor will want to be paid less to care for patients in higher risk areas, such as centers of lower socioeconomic status, where patients may be inherently sicker?

And is there a conflict of interest when doctors are paid more to do less? There is the potential not only for patients to suffer if doctors cut back on tests and treatments, but also for the physician to face malpractice lawsuits – the new Medicare law offers inadequate liability protection for doctors who are being required to keep medical expenses down simply to get paid for their work.

Up to this point, I have managed to play by the rules that Medicare has set. Yes, I’ve had to spend hours of additional work on documentation, and hire additional staff to help me comply with the new rules. And yes, I’ve taken a pay cut from Medicare this year because I chose not to invest another $15,000 in an electronic patient portal, as required by the second phase of Meaningful Use. But so far I have been able to absorb the increased expenses and decrease in payment, and I have been able to continue to care for my Medicare patients.

In 2017, this may no longer be the case.

I wonder if I will be able to afford to care for Medicare patients as a solo physician, not knowing if or when I will be paid, while my expenses remain fixed or increase with inflation. On the other hand, I do not want to return to a large group, losing the freedom to run my own practice in the way that I feel is best for me, my patients, and my staff.

I understand that whoever pays the bills makes the rules. The only recourse a player has is to choose whether or not to play the game, especially when the deck is stacked against them.

Perhaps the rules will change again before 2017, but it will take a loud voice not only from physicians and health care providers, but from you, my Medicare patients.

Sincerely,
Rebekah Bernard, MD

Rebekah Bernard is a family physician and the author of How to Be a Rock Star Doctor: The Complete Guide to Taking Back Control of Your Life and Your Profession. She can be reached at How to Be a Rock Star Doctor.